BPCIA

  • Read more: Year in Review: Biosimilars
    Article

    Year in Review: Biosimilars

    In November 2020, the FDA released its most recent draft guidance for industry on biosimilarity and interchangeability

    Graphic rendering of antibodies in the bloodstream.